Language:

Epilepsy in adults

The Lancet (British edition), 2019-02, Vol.393 (10172), p.689-701 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32596-0 ;PMID: 30686584

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Epilepsy in adults
Author: Thijs, Roland D ; Surges, Rainer ; O'Brien, Terence J ; Sander, Josemir W
Subjects: Adult ; Adults ; Age ; Anticonvulsants - therapeutic use ; Brain ; Brain research ; Consultants ; Convulsions & seizures ; Drug resistance ; Epidemiology ; Epilepsy ; Epilepsy - diagnostic imaging ; Epilepsy - drug therapy ; Epilepsy - genetics ; Epilepsy - physiopathology ; Fees & charges ; Funding ; High income ; Humans ; Infants ; Low income groups ; Medical research ; Mortality ; Neuroimaging ; Neuromodulation ; Pharmacogenomics ; Pharmacology ; Prognosis ; Public speaking ; R&D ; Research & development ; Risk analysis ; Risk factors ; Seizing ; Seizures ; Structure-function relationships ; Surgery
Is Part Of: The Lancet (British edition), 2019-02, Vol.393 (10172), p.689-701
Description: Epilepsy is one of the most common serious brain conditions, affecting over 70 million people worldwide. Its incidence has a bimodal distribution with the highest risk in infants and older age groups. Progress in genomic technology is exposing the complex genetic architecture of the common types of epilepsy, and is driving a paradigm shift. Epilepsy is a symptom complex with multiple risk factors and a strong genetic predisposition rather than a condition with a single expression and cause. These advances have resulted in the new classification of epileptic seizures and epilepsies. A detailed clinical history and a reliable eyewitness account of a seizure are the cornerstones of the diagnosis. Ancillary investigations can help to determine cause and prognosis. Advances in brain imaging are helping to identify the structural and functional causes and consequences of the epilepsies. Comorbidities are increasingly recognised as important aetiological and prognostic markers. Antiseizure medication might suppress seizures in up to two-thirds of all individuals but do not alter long-term prognosis. Epilepsy surgery is the most effective way to achieve long-term seizure freedom in selected individuals with drug-resistant focal epilepsy, but it is probably not used enough. With improved understanding of the gradual development of epilepsy, epigenetic determinants, and pharmacogenomics comes the hope for better, disease-modifying, or even curative, pharmacological and non-pharmacological treatment strategies. Other developments are clinical implementation of seizure detection devices and new neuromodulation techniques, including responsive neural stimulation.
Publisher: England: Elsevier Ltd
Language: English
Identifier: ISSN: 0140-6736
EISSN: 1474-547X
DOI: 10.1016/S0140-6736(18)32596-0
PMID: 30686584
Source: ProQuest One Psychology
MEDLINE
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Epilepsy in adults

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32596-0 ;PMID: 30686584

Searching Remote Databases, Please Wait